Clinical and Angiographic Characteristics of Patients Likely to Have Vulnerable Plaques

Fatma Bektas, Hector Garcia Garcia, V Farooq, A Maehara, K Xu, P Genereux, Roberto Diletti, Takashi Muramatsu, M Fahy, G Weisz, GW Stone, PWJC (Patrick) Serruys

Research output: Contribution to journalArticleAcademic

56 Citations (Scopus)


OBJECTIVES This study sought to determine the clinical and angiographic variables that would identify patients with high-risk "vulnerable" coronary plaques. BACKGROUND In the PROSPECT (Providing Regional Observations to Study Predictors of Events in the Coronary Tree) study, in patients successfully treated for acute coronary syndrome (ACS), plaque composition, plaque burden, and minimal lumina] area as detected by 3-vessel radiofrequency intravascular ultrasound (IVUS) imaging were associated with an increased risk of developing future events from untreated atherosclerotic lesions (vulnerable plaques). Whether baseline demographic and angiographic METHODS On the basis of 3-vessel radiofrequency IVUS imaging, patents in the PROSPECT trial were classified in 2 groups according to whether or not one or more untreated high-risk plaques were present, defined as having >= 2 high-risk features (a thin-cap fibroatheroma, plaque burden >= 70%, and/or minimal luminal area <= 4 mm(2)). RESULTS The high-risk group (those with one or more high-risk lesions) had higher Framingham risk score (7.5 +/- 3.4 vs. 6.9 +/- 3.3; p = 0.04), more extensive coronary artery disease, and more nonculprit lesion related cardiovascular events during the 3-year follow-up (hazard ratio: 2.63; 95% confidence interval: 1.62 to 3.66; p < 0.0001). However, demographic factors had poor discrimination in detecting high-risk patients (area under the curve 0.55), and discrimination was only slightly improv CONCLUSIONS Clinical and angiographic characteristics had poor predictive accuracy in identifying patients with untreated high-risk plaques related to future adverse events. This finding highlights the potential value of comprehensive 3-vessel imaging assessment (either invasive or noninvasive) to evaluate plaque phenotype for more accurate risk stratification of patients admitted with ACS. (C) 2013 by the American College of Cardiology Foundation
Original languageUndefined/Unknown
Pages (from-to)1263-1272
Number of pages10
JournalJACC-cardiovascular imaging
Issue number12
Publication statusPublished - 2013

Cite this